These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3571941)

  • 1. The prevalence of abnormal involuntary movements among chronic schizophrenics.
    Guy W; Ban TA; Wilson WH
    Int Clin Psychopharmacol; 1986 Apr; 1(2):134-44. PubMed ID: 3571941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
    Owens DG; Johnstone EC; Frith CD
    Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
    Zhang XY; Yu YQ; Sun S; Zhang X; Li W; Xiu MH; Chen DC; Yang FD; Zhu F; Kosten TA; Kosten TR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1765-9. PubMed ID: 21723906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC; Root L; Marmion J; Molinari V; Adams GL
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in schizophrenics. Prevalence, distribution and relationship to neurological "soft" signs in Nigerian patients.
    Gureje O
    Acta Psychiatr Scand; 1987 Nov; 76(5):523-8. PubMed ID: 2893513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nithsdale schizophrenia survey. V. Follow-up of tardive dyskinesia at 3 1/2 years.
    Robinson AD; McCreadie RG
    Br J Psychiatry; 1986 Nov; 149():621-3. PubMed ID: 2880631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not all that moves is tardive dyskinesia.
    Khot V; Wyatt RJ
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: age and sex differences in hospitalized schizophrenics.
    Smith JM; Oswald WT; Kucharski LT; Waterman LJ
    Psychopharmacology (Berl); 1978 Jul; 58(2):207-11. PubMed ID: 98792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
    J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
    Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
    Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
    Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
    Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.